Healthy high growth potential

Results

13

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

13 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
KURN
CHF 20.503.3%-23.3%CHF 808.5mCHF 35.40412.261.9%n/aPharmaceuticals & Biotech
CNTL
CHF 7.3046.0%381.5%CHF 595.7mCHF 7.5276.134.1%n/aFood, Beverage & Tobacco
SKAN
CHF 49.15-1.9%-34.4%CHF 1.1bCHF 62.5067.928.8%0.4%Pharmaceuticals & Biotech
LMN
CHF 12.700%-19.1%CHF 134.7mCHF 19.1612.620.5%3.0%Consumer Services
MMTX
CHF 0.28-17.8%n/aCHF 42.7mCHF 3.4166.485.4%n/aPharmaceuticals & Biotech
COTN
CHF 380.809.4%63.0%CHF 3.0bCHF 369.80242.457.9%0.1%Tech
HUBN
CHF 256.00-1.0%199.8%CHF 4.7bCHF 248.7563.625.8%0.8%Capital Goods
WIHN
CHF 12.68-1.6%18.3%CHF 53.9mn/a3.5140.2%n/aSemiconductors
DESN
CHF 291.00-0.3%1.0%CHF 4.0bCHF 412.5038.826.5%0%Pharmaceuticals & Biotech
KARN
CHF 215.50-6.7%-19.3%CHF 1.7bCHF 325.8543.430.5%2.8%Capital Goods
COPN
CHF 69.90-1.3%18.9%CHF 1.1bCHF 128.3811.842.0%2.8%Pharmaceuticals & Biotech
SRAIL
CHF 22.18-0.6%12.0%CHF 2.2bCHF 23.5025.228.0%2.3%Capital Goods
IFCN
CHF 170.805.3%69.1%CHF 4.2bCHF 152.1461.121.7%1.2%Tech
Page 1 of 1